Orasure Tech Stock
Pros and Cons of Orasure Tech in the next few years
Pros
?
C******** o* t** e**********
?
B****
?
S********** s********
Cons
?
M***** P*******
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Orasure Tech vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Orasure Tech | 0.770% | 0.775% | 0.000% | -33.673% | -23.977% | -12.162% | -78.689% |
SI-BONE Inc | -0.680% | -5.229% | -3.333% | 5.072% | 11.538% | - | - |
scPharmaceuticals | -1.870% | 15.523% | 11.323% | -11.469% | 15.309% | -24.372% | -38.754% |
Lantheus Holdings Inc | 0.950% | 5.355% | 5.730% | -37.085% | -18.344% | 7.909% | - |
Comments
OraSure Technologies, Inc. (NASDAQ: OSUR) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Show more
Ratings data for OSUR provided by MarketBeat
OraSure Technologies, Inc. (NASDAQ: OSUR) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Show more
Ratings data for OSUR provided by MarketBeat
OraSure Technologies, Inc. (NASDAQ: OSUR) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Show more
Ratings data for OSUR provided by MarketBeat
News

OraSure Stock: Insiders Bet Big Near 52-Week Low
OraSure Technologies' stock is experiencing significant insider buying activity as multiple executives made substantial investments while shares trade near their 52-week low of €2.69. CEO Carrie